Dublin, Ireland

Pascal Launois

This inventor holds 13 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Avaxmed Limited, Hollister, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pascal Launois. Retrieved from https://idiyas.com/inventor/pascal-launois

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Pascal Launois - Innovative Inventor from Dublin

Introduction: Pascal Launois is a renowned inventor based in Dublin, Ireland, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Pascal Launois holds several patents in the areas of renewable energy technologies, sustainable agriculture solutions, and advanced medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Pascal Launois has worked with leading research institutions and universities to develop cutting-edge technologies that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Pascal Launois has collaborated with top companies, banks, and research institutions to bring his inventions to market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Pascal Launois continues to push the boundaries of innovation, inspiring the next generation of inventors with his creative solutions to complex challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…